LPL Financial LLC - INTRA CELLULAR THERAPIES INC ownership

INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 178 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.

Quarter-by-quarter ownership
LPL Financial LLC ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q3 2023$489,125
-3.5%
9,390
+17.3%
0.00%
Q2 2023$506,750
+18.3%
8,003
+1.1%
0.00%
Q1 2023$428,462
-5.8%
7,913
-7.9%
0.00%
Q4 2022$454,874
+5.8%
8,596
-7.0%
0.00%
Q3 2022$430,000
-16.2%
9,241
+2.8%
0.00%
Q2 2022$513,000
-26.7%
8,992
-21.4%
0.00%
-100.0%
Q1 2022$700,000
-6.0%
11,442
-19.7%
0.00%0.0%
Q4 2021$745,000
+34.0%
14,241
-4.5%
0.00%0.0%
Q3 2021$556,000
-6.2%
14,917
+2.7%
0.00%0.0%
Q2 2021$593,000
+27.8%
14,526
+6.1%
0.00%0.0%
Q1 2021$464,0000.0%13,689
-6.2%
0.00%0.0%
Q4 2020$464,000
+24.7%
14,600
+0.7%
0.00%0.0%
Q3 2020$372,000
+10.7%
14,495
+10.7%
0.00%0.0%
Q2 2020$336,000
+80.6%
13,098
+8.4%
0.00%
Q1 2020$186,000
-68.0%
12,083
-28.7%
0.00%
-100.0%
Q4 2019$582,000
+334.3%
16,955
-5.7%
0.00%
Q3 2019$134,00017,9730.00%
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q4 2020
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 700,000$42,833,0008.57%
SILVERARC CAPITAL MANAGEMENT, LLC 308,819$18,897,0007.82%
Vahanian & Associates Financial Planning Inc. 45,533$2,786,0006.44%
DCF Advisers, LLC 238,500$14,594,0006.39%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 50,956$20,930,0004.72%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,531,923$93,738,0002.86%
Nicholas Investment Partners, LP 562,373$34,412,0002.45%
Bellevue Group AG 3,429,619$209,859,0002.44%
WASATCH ADVISORS LP 7,477,868$457,571,0002.25%
Quantum Private Wealth, LLC 73,772$4,514,0001.95%
View complete list of INTRA CELLULAR THERAPIES INC shareholders